For research use only. Not for therapeutic Use.
2-(Trifluoromethyl)-[1,2,4]triazolo[1,5-a]pyrazine(CAT: L032115) is a nitrogen-rich heterocyclic compound valued in pharmaceutical and chemical research for its unique structural and electronic properties. The triazolopyrazine core, combined with a trifluoromethyl group at the 2-position, enhances its metabolic stability, lipophilicity, and potential for biological activity. The trifluoromethyl group, a common pharmacophore, improves bioavailability and target binding due to its electron-withdrawing nature. This compound serves as a versatile scaffold for developing inhibitors, receptor modulators, and other bioactive agents, making it useful in drug discovery programs, particularly those focused on central nervous system and oncology targets. Its structure enables modifications that can optimize potency and selectivity for specific biochemical pathways.
Catalog Number | L032115 |
CAS Number | 681249-56-9 |
Molecular Formula | C6H3F3N4 |
Purity | ≥95% |
IUPAC Name | 2-(trifluoromethyl)-[1,2,4]triazolo[1,5-a]pyrazine |
InChI | InChI=1S/C6H3F3N4/c7-6(8,9)5-11-4-3-10-1-2-13(4)12-5/h1-3H |
InChIKey | PODZNIVAQJSKBB-UHFFFAOYSA-N |